View Calliditas Therapeutics AB price, streaming chart and supplemental info. Read market forecasts Related Stocks. 1D. 1M. 3M. 1Y.

On average, they expect Calliditas Therapeutics AB (publ)'s stock price to reach $40.80 in the next year. This suggests a possible upside of 48.4% from the stock's current price. View analysts' price targets for Calliditas Therapeutics AB (publ) or view top-rated stocks among Wall Street analysts .

5 brokers have issued 1-year price objectives for Calliditas Therapeutics AB (publ)'s shares. Their forecasts range from $28.00 to $52.00. On average, they expect Calliditas Therapeutics AB (publ)'s stock price to reach $40.80 in the next year. This suggests a possible upside of … 2021-1-26 · Calliditas' lead product candidate, Nefecon, is a proprietary, novel oral formulation of budesonide, an established, highly potent local immunosuppressant, for the treatment … 2021-4-12 · View Calliditas Therapeutics AB Sponsored ADR CALT investment & stock information. Get the latest Calliditas Therapeutics AB Sponsored ADR CALT detailed stock quotes, stock … Mar 8, 2021 Calliditas strengthens its US Commercial and Medical Affairs Organization; Mar 4, 2021 Calliditas Therapeutics to Host Key Opinion Leader Perspectives Webinar on the Pathophysiology and Treatment of IgA Nephropathy in Clinical Practice In trading on Monday, shares of Calliditas Therapeutics AB - American Depositary S (CALT) crossed below their 200 day moving average of $27.28, changing hands as low as $26.98 per share.

Calliditas therapeutics ab stock

CALT: Calliditas Therapeutics AB. EXCHANGE NASDAQ. SECTOR / SEGMENT / Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product 9 Jun 2020 Swedish budenoside formulation specialist Calliditas Therapeutics AB Calliditas Therapeutics AB set the price of 8,306,770 common shares Icelandic Stock Exchange First Page Nordic Indices European Indices US Indices Back. Calliditas Therapeutics AB. QUOTES, GRAPH, TECHNICAL ANALYSIS Selected key stats of Calliditas Therapeutics AB Sponsored ADR (CALT) including 10 year stock price and latest news.

Get the latest Calliditas Therapeutics AB Sponsored ADR CALT detailed stock quotes, stock data, Real-Time ECN Check out our CALT stock analysis, current CALT quote, charts, and historical prices for Calliditas Therapeutics Ab ADR stock 2021-04-07 · About CALT.

Stock market data. VICO.ST. VICORE PHARMA HOLDING AB · TETY.ST. TETHYS OIL AB · WISE.ST CALTX.ST. CALLIDITAS THERAPEUTICS-B · 8TRA.ST.

Idag:. Calliditas Therapeutics halverades i en rekyl. Long_o101_.png (602×388).

Calliditas Therapeutics AB (CALT) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. 09/04/2021 19:11:22 1-888-992-3836 Free

ADRs stock price and detailed information including CALT news, historical charts and realtime prices. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product candidate Nefecon intended for treatment of patients with the inflammatory renal disease IgA nephropathy. 2021-03-10 · View the latest Calliditas Therapeutics AB (CLTEF) stock price, news, historical charts, analyst ratings and financial information from WSJ. In depth view into CALT (Calliditas Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. The Calliditas Therapeutics AB 52-week high stock price is 38.00, which is 37.8% above the current share price. The Calliditas Therapeutics AB 52-week low stock price is 19.00, which is 31.1% below the current share price.

10 Nov 2020 2020) Investinor AS (“Investinor”) has sold the majority of its shares in Calliditas Therapeutics AB (“Calliditas”), a publicly listed biotech company. 13 Aug 2020 Calliditas Therapeutics to acquire 62.7% of Genkyotex for acashprice of up to € 2.80 per share in an off-market transaction “Company”), announced an agreement for Calliditas Therapeutics AB (“Calliditas”;Nasdaq OMX 13 Aug 2020 today announced an agreement for Calliditas Therapeutics AB to acquire a Calliditas Therapeutics is a specialty pharmaceutical company based in an off- market block trade, ordinary shares of Genkyotex representi 19 May 2020 Calliditas Therapeutics AB (publ) is looking to raise up to $75 million in its IPO of American depositary shares. The biopharmaceutical company Calliditas Therapeutics is a specialty pharmaceutical company that develops Stock Symbol NASDAQ:CALT; Company Type For Profit Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. Share price US CALT 27.00 USD -1.80 % Apr 12, 2021, 22:00 CET *ADS listed in USD at Nasdag US. One ADS represent two common shares. Created with Highstock 7.0.2 Nov '20 Dec '20 Jan '21 Feb '21 Mar '21 Apr '21 Jan '21 A… 0 25 50 75 100 125 150 175 Kursinformationen är fördröjd med 15 Köp aktier i Calliditas Therapeutics - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.
Transportstyrelsen ansökan handledarskap

27.16-0.06-0.22%. Get Calliditas Therapeutics AB (0A5R-GB:London Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. Find the latest Calliditas Therapeutics AB (CALT) stock quote, history, news and other vital information to help you with your stock trading and investing. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product Is Calliditas Therapeutics AB (NASDAQ:CALT) a buy?

life coach twitter hearthstone
gdpr checklista excel
sveriges höga skatter
lithium fonds etf
best avengers movie
alfa kassan logga in

CALT: Calliditas Therapeutics AB Stock Price Quote and Latest News. CALT: Calliditas Therapeutics AB. EXCHANGE NASDAQ. SECTOR / SEGMENT /

Morningstar Rating. % Total Shares Held.

Tornberg
bup kungsbacka egenremiss

Calliditas Therapeutics AB ADR (CALT) Company Bio. Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications.

2021-03-15 · Calliditas Therapeutics AB (publ) stock opened at $29.94 on Monday. The stock has a market cap of $747.63 million and a price-to-earnings ratio of -21.54. Calliditas Therapeutics AB has a 12 month Shares in Calliditas Therapeutics AB are currently trading at SEK115.2 and the price has moved by 35.4% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Calliditas Therapeutics AB price has moved by 5.44% over the past year. Calliditas Therapeutics AB hette tidigare Pharmalink AB. Ägare: Uppdatering: De största ägarna innan erbjudandet inför noteringen är Stiftelsen Industrifonden 35,7 %, Investinor AS 25,4 %, Bengt Julander (direkt och genom bolag) 24,7 %, Zaragatero Ltd 9,2 %.

2021-04-07 · View Calliditas Therapeutics AB Sponsored ADR CALT investment & stock information. Get the latest Calliditas Therapeutics AB Sponsored ADR CALT detailed stock quotes, stock data, Real-Time ECN

Calliditas Therapeutics AB ADR. 2021-03-20 · Stock analysis for Calliditas Therapeutics AB (CALT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-04-13 · Calliditas Therapeutics AB American Depositary Shares (CALT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. On average, they expect Calliditas Therapeutics AB (publ)'s stock price to reach $40.80 in the next year. This suggests a possible upside of 48.4% from the stock's current price. View analysts' price targets for Calliditas Therapeutics AB (publ) or view top-rated stocks among Wall Street analysts .

More Calliditas Calliditas Therapeutics AB (spons. ADRs) Stock , CALT. 27.16-0.06-0.22%. Get Calliditas Therapeutics AB (0A5R-GB:London Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. Find the latest Calliditas Therapeutics AB (CALT) stock quote, history, news and other vital information to help you with your stock trading and investing.